The U.S. Strategic National Reserve includes 1.7 million doses of tecovirimat—a smallpox treatment that might also be effective against monkeypox, a rare disease that has been diagnosed in dozens of American and European patients in recent weeks.
Subscribe to:
Post Comments (Atom)
< + > Provider Enrollment is a Data Problem Hiding in the Denial Queue
The following is a guest article by Madison Gardner, President at AMS Solutions, Inc. A claim can pass every check a practice controls and ...
No comments:
Post a Comment